Ifosfamide



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 17.7%
Sarcoma 11.6%
Drug Use For Unknown Indication 7.0%
Germ Cell Cancer 6.9%
Bone Sarcoma 6.8%
Prophylaxis 6.3%
Rhabdomyosarcoma 6.3%
Non-hodgkin's Lymphoma 5.6%
Ewing's Sarcoma 5.1%
Hodgkin's Disease 5.0%
Sarcoma Metastatic 2.7%
Diffuse Large B-cell Lymphoma 2.6%
Nephroblastoma 2.5%
Burkitt's Lymphoma 2.4%
Prophylaxis Of Nausea And Vomiting 2.3%
Head And Neck Cancer 2.2%
Premedication 1.8%
Synovial Sarcoma 1.8%
Lymphoma 1.7%
Neoplasm Malignant 1.7%
Encephalopathy 16.6%
Vomiting 8.0%
Thrombocytopenia 7.6%
Neurotoxicity 6.2%
Febrile Neutropenia 5.5%
Death 5.2%
Neutropenic Sepsis 5.2%
Septic Shock 5.2%
Neutropenia 4.2%
Sepsis 4.2%
Tremor 3.8%
Acute Myeloid Leukaemia 3.5%
Mucosal Inflammation 3.5%
Myoclonus 3.5%
Urinary Incontinence 3.5%
Pneumonia 3.1%
Renal Impairment 3.1%
Acute Promyelocytic Leukaemia 2.8%
Renal Tubular Disorder 2.8%
Rickets 2.8%
Secondary
Burkitt's Lymphoma 11.6%
Diffuse Large B-cell Lymphoma 10.0%
Ewing's Sarcoma 8.3%
Bone Sarcoma 7.6%
Sarcoma 7.0%
Product Used For Unknown Indication 6.9%
Prophylaxis Of Nausea And Vomiting 5.6%
Drug Use For Unknown Indication 5.1%
Hodgkin's Disease 4.8%
Rhabdomyosarcoma 4.6%
Neoplasm Malignant 4.1%
Non-hodgkin's Lymphoma 3.6%
Lymphoma 3.5%
Sarcoma Metastatic 3.0%
Burkitt's Leukaemia 2.7%
Acute Lymphocytic Leukaemia 2.7%
Prophylaxis 2.7%
B-cell Lymphoma 2.2%
Synovial Sarcoma 2.1%
Foetal Exposure During Pregnancy 1.8%
Off Label Use 10.4%
Thrombocytopenia 9.9%
Febrile Neutropenia 9.8%
Neutropenia 7.7%
Acute Myeloid Leukaemia 6.4%
Vomiting 5.8%
Mucosal Inflammation 5.3%
Death 4.8%
Encephalopathy 4.4%
Myelodysplastic Syndrome 4.4%
Hearing Impaired 4.2%
Infection 3.7%
Sepsis 3.7%
White Blood Cell Count Decreased 3.6%
Pyrexia 3.4%
Toxicity To Various Agents 3.4%
Premature Baby 2.6%
Pancytopenia 2.3%
Stomatitis 2.3%
Febrile Bone Marrow Aplasia 2.2%
Concomitant
Drug Use For Unknown Indication 15.7%
Diffuse Large B-cell Lymphoma 8.3%
Product Used For Unknown Indication 8.2%
Prophylaxis 7.9%
Infection Prophylaxis 7.5%
Chemotherapy 7.0%
Non-hodgkin's Lymphoma 5.4%
Ewing's Sarcoma Recurrent 5.1%
Lymphoma 4.7%
B-cell Lymphoma 3.7%
Bone Sarcoma 3.6%
Prophylaxis Against Graft Versus Host Disease 3.4%
Premedication 2.8%
Prophylaxis Of Nausea And Vomiting 2.7%
Neoplasm Malignant 2.7%
Bone Marrow Conditioning Regimen 2.7%
Nuclear Magnetic Resonance Imaging 2.2%
Burkitt's Lymphoma 2.2%
Hodgkin's Disease 2.0%
Pelvic Neoplasm 2.0%
Thrombocytopenia 11.2%
Febrile Neutropenia 10.7%
Vomiting 10.7%
Pyrexia 8.7%
Sepsis 5.8%
White Blood Cell Count Decreased 5.8%
White Blood Cell Count Increased 4.9%
Lymphoma 4.4%
Vaginal Infection 3.9%
Asthenia 3.4%
Nephrogenic Systemic Fibrosis 3.4%
Neutropenia 3.4%
Renal Failure Acute 3.4%
Disease Progression 2.9%
Drug Ineffective 2.9%
Enterococcal Infection 2.9%
Nausea 2.9%
Rash 2.9%
Staphylococcal Infection 2.9%
Tetany 2.9%
Interacting
Ewing's Sarcoma 24.0%
Non-hodgkin's Lymphoma Unspecified Histology Aggressive 16.6%
Non-hodgkin's Lymphoma 12.4%
Premedication 9.2%
Ovarian Cancer Stage Iii 6.5%
Prophylaxis Of Nausea And Vomiting 6.5%
Oral Candidiasis 3.2%
Product Used For Unknown Indication 3.2%
Ovarian Neoplasm 2.8%
Sarcoma Uterus 2.8%
Chemotherapy 1.8%
Ovarian Cancer Metastatic 1.8%
Uterine Leiomyosarcoma 1.8%
Bone Sarcoma 1.4%
Metastasis 1.4%
Antiemetic Supportive Care 0.9%
Antifungal Prophylaxis 0.9%
Nausea 0.9%
Prophylaxis 0.9%
Rhabdomyosarcoma 0.9%
Renal Impairment 13.9%
Vomiting 13.9%
Mental Status Changes 11.1%
Encephalopathy 8.3%
Neurotoxicity 8.3%
Paraesthesia 8.3%
Agranulocytosis 5.6%
Drug Interaction 5.6%
Leukopenia 5.6%
Neutropenia 5.6%
Agitation 2.8%
Convulsion 2.8%
Neoplasm Progression 2.8%
Neuropathy Peripheral 2.8%
Toxic Encephalopathy 2.8%